Melphalan Purification via Acidic Isolation and Reflux

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current purification methods for melphalan result in a highly unstable solid at neutral pH, leading to the formation of impurity 'dimer' and low purity levels, with most methods achieving only 96% to 99% purity, which is difficult to filter and requires high limit values as per the European Pharmacopeia.

Innovation Solution

A method involving treatment with HCl 37% under reflux, followed by isolation in water, methyl-tert-butyl ether, and diethylamine at pH=2, and subsequent washing with ethanol to achieve melphalan with purity greater than 99.5%, specifically targeting the removal of impurities like 'dimer' and enhancing stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If current purification methods are used to isolate melphalan, then the product can be obtained, but the purity is low (96-99%) and the solid is highly unstable at neutral pH

Engineering Contradiction:
ImprovepurityVSAvoidstability
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The invention changes the isolation pH parameter from neutral (pH 7) to acidic (pH 2) conditions. This parameter change transforms the isolated solid from highly unstable at neutral pH to stable at acidic pH, while simultaneously achieving higher purity levels (99.5-99.8%). The acidic isolation conditions prevent dimer formation and improve both purity and stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the conventional mechanical filtration approach with a chemical approach using acidic isolation conditions. Instead of relying on physical filtration of unstable neutral pH solids, the method uses acidified conditions to maintain stability during isolation, eliminating the need for complex handling procedures and improving both purity and stability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If current purification methods are used, then melphalan can be isolated, but impurity 'dimer' is formed and purity levels remain low

Engineering Contradiction:
ImprovepurityVSAvoidimpurity formation
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The invention applies preliminary anti-action by isolating melphalan at acidic pH (pH 2) before any dimerization can occur. This preliminary stabilization at low pH prevents the formation of the harmful dimer impurity that would otherwise form during neutral pH isolation. The acidified conditions act as a preventive measure against impurity generation.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

By changing the isolation pH parameter from neutral to acidic conditions, the invention fundamentally alters the chemical environment to prevent dimer formation. This parameter change transforms the isolation process from one that generates impurities to one that maintains high purity (99.5-99.8%) by preventing harmful side reactions.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If melphalan is isolated at neutral pH, then the product can be obtained, but it forms a highly unstable solid that is difficult to filter

Engineering Contradiction:
ImprovefilterabilityVSAvoidstability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The invention changes the isolation pH parameter from neutral (pH 7) to acidic (pH 2), which fundamentally improves both stability and filterability. The acidic conditions produce a stable solid that is easy to filter, eliminating the difficulties associated with neutral pH isolation where the solid is both unstable and difficult to filter.

Inventive Principle:
Principle #35Parameter changes

4Productivity

If conventional purification steps are used, then melphalan can be obtained, but multiple steps are required and time is consumed

Engineering Contradiction:
Improveproduction efficiencyVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention merges the purification and isolation steps into a single operation by performing both functions under acidic conditions. This consolidation eliminates the need for separate purification and isolation steps, reducing overall processing time while achieving higher purity levels (99.5-99.8%) compared to conventional multi-step methods.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

By changing the isolation pH parameter to acidic conditions, the invention achieves both faster processing and higher purity. The acidic conditions enable a single-step isolation that simultaneously purifies and stabilizes the product, improving productivity without sacrificing manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves melphalan with HPLC purity greater than 99.5%, preferably 99.8%, and significantly reduces the formation of undesirable by-products, such as the 'dimer', resulting in a more stable product with lower impurity levels.

Implementation Method 1

the treatment of a compound of formula IV in HCl 37% under reflux

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

the isolation of the compound obtained from step (a) in the presence of water, methyl-tert-butyl ether and diethylamine at pH=2

Methodology Applied
Scientific EffectLiquid-Liquid Extraction: Liquid-Liquid Extraction

Implementation Method 3

washing the compound obtained from step (b) with a linear or branched C1-C4 alcohol, preferably selected among methanol, ethanol and isopropanol

Methodology Applied
Scientific EffectWashing:

Data Source

PatentUS9663450B2Process for the purification of melphalan
Publication Date: 2017.05.30 FARMABIOS
  • US9663450B2 patent drawing
  • US9663450B2 patent drawing
  • US9663450B2 patent drawing

AI summary

A method for the purification and preparation of melphalan that allows to obtain melphalan with purity higher than 99.5% is described.